SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

80,708.15 -291.25
( -0.36%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

58,738.13 1,303.36
(2.27%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Astal Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

512600

INE307N01014

75.6664185

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

26.9

261.52

EPS(TTM)

Face Value()

Div & Yield %

2.22

Back

hindustan unilever ltd

Remi Edelstahl Tubulars standalone net profit rises 87.38% in the September 2026 quarter

Nov 07,2026

Net profit of Remi Edelstahl Tubulars rose 87.38% to Rs 1.93 crore in the quarter ended September 2026 as against Rs 1.03 crore during the previous quarter ended September 2025. Sales rose 60.51% to Rs 53.69 crore in the quarter ended September 2026 as against Rs 33.45 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	53.69	33.45	61
OPM %	7.99	7.38	-
PBDT	3.46	2.27	52
PBT	2.54	1.40	81
NP	1.93	1.03	87

80,708.15 -291.25 ( -0.36%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

58,738.13 1,303.36 (2.27%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)